Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment of cystinuria, approved by the US Food and Drug Administration (FDA) ...

Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment of cystinuria, approved by the US Food and Drug Administration (FDA) ...

Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment of cystinuria, approved by the US Food and Drug Administration (FDA) ...

Some experts believe that having two mutations (homozygous) may lead to more serious problems. There are two variants, or forms, of mutations that can occur on the MTHFR gene. The specific ...

Major depressive disorder (MDD) is a common condition that imposes a high disease burden on the individual patient (1). However, not only the affected patients, but also the healthcare system and ...

Here, we describe a patient with early onset combined immunodeficiency who survived to adolescence. The patient harbors a homozygous missense mutation at amino acid 395 of the IKBKB gene, which ...